Last reviewed · How we verify

NCT06713512: ESSENTIAL

InvEstigating oeStrogen Signalling and the Effect upoN the exTracelluar Matrix In pAtients With Obstructive Lung Disease

Recruiting now Last updated 3 December 2024
What this trial tests

trial testing No intervention in Chronic Obstructive Lung Disease in 100 participants. Currently enrolling.

Timeline
1 December 2024
Primary endpoint
1 January 2026
1 November 2028

Quick facts

Lead sponsorGuy's and St Thomas' NHS Foundation Trust
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment100
Start date1 December 2024
Primary completion1 January 2026
Estimated completion1 November 2028
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Guy's and St Thomas' NHS Foundation Trust

Who can join

Adults 18 to 99, any sex, with Chronic Obstructive Lung Disease or Respiratory Ilness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to understand the role of oestrogen in patients with asthma and Chronic Obstructive Pulmonary Disorder (COPD). Therefore, what is the effect of oestrogen in these participants compared to controls (those without disease). The study hypothesises that oestrogen loss in patients with asthma and COPD causes accelerated lung function decline and changes to lung structure. It will investigate if this is mediated by inflammation, immune host response or elastin and collagen changes. It is an observational prospective cohort study aiming to recruit healthy controls, and people with asthma or COPD), and/or the menopause.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Chronic Obstructive Lung Disease

Currently open trials in the same condition.

Other Guy's and St Thomas' NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06713512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing